While some prior studies have demonstrated localized neuroinflammation and neurodegeneration at the site of cerebral ET-1 application [43], others suggest that the transient vasoconstrictive effect does not generate significant stroke damage in mice [19], possibly due to lack of penetration to deeper brain regions and the short biologic half-life of ET-1 [44]. Here, EDN1 is linked to stroke disorder.